PolyPid Ltd. is rated a BUY with a $7.25 price target, implying a 35% upside before the FDA decision on its drug D-PLEX100 scheduled for November 28, 2026. The drug showed promising Phase 3 trial results in reducing surgical site infections, although prior trial failures and regulatory risks remain concerns. The company has a partnership with Azurity for commercialization in the U.S. and Canada, with potential milestone payments of $320 million and attractive royalty rates. Despite risks like FDA approval uncertainty and slow market adoption, the current valuation may undervalue the drug's potential.
PolyPid's upcoming FDA decision is the subject, with Pluang's Health-sector data as of Nov 04, 2026 16:01 WIB offering market context. Of 150 priced Health-sector US stocks tradable on Pluang, 74 rose and 65 fell today. Notable movers include CGC at USD 0.74 with a 4.70% increase and 100% buy order activity, NVO at USD 41.98 up 4.45% with 90% buy orders, and CNC at USD 69.90 rising 3.59%.
Sampo Oyj has canceled 37,827,020 of its own A-shares as per the board's decision, with the cancellation registered today. These shares were acquired through a buyback program announced on May 6, 2026, and repurchased between May 7 and September 24, ...
Solvay's Q3 2026 underlying net sales fell 3.3% organically to €1,031 million, impacted by the Middle East conflict and weak soda ash markets. EBITDA dropped 26.6% organically to €173 million, partly due to a €25 million impact from the conflict and ...
STMicroelectronics announced a unified STM32 microcontroller platform that spans industrial, automotive, and robotics applications, enabling developers to reuse architectures, software, and tools across these sectors. The new STM32A family extends th...
dsm-firmenich announced a strong Q3 2026 trading update with 5% like-for-like sales growth and an improved Adjusted EBITDA margin of 20.4%. The company’s performance was driven by volume growth across its three business units: Perfumery & Beauty, Tas...
VEON's Banglalink has launched Mukto Pay, a new digital payments platform in Bangladesh, following its Payment Service Provider license from Bangladesh Bank. Mukto Pay allows users across all mobile operators to send money, pay bills, recharge accoun...
